Collective Health Valued at $1.5 Billion After Funding Infusion
(Bloomberg) -- Startup Collective Health has reached a valuation of about $1.5 billion after raising $280 million in new funding in the latest sign that investors are eager to bet on private health-care companies.
Collective Health, founded in 2013, offers employers a way to knit together various health benefits -- medical, prescription drug, dental, vision, as well as other specialized offerings — on a single technology platform. Among its new investors is Health Care Service Corporation, a major seller of Blue Cross Blue Shield health plans, as an investor and business partner. HCSC'S self-insured employer clients will be able to opt-in to use Collective Health's systems, giving them a more complete view into what they pay for health care.
Globally, investors put $31.6 billion into health-care ventures in the first quarter, according to researcher CB Insights, a record high. The average size of digital-health deals jumped 45% from last year, to about $46 million in the quarter, data from investment firm Rock Health show. Collective Health's recent investments bring its total fundraising to about $720 million.
Health care “needs to become like anything else that you buy for the enterprise: a primarily data driven-decision,” Ali Diab, Collective Health's co-founder and chief executive officer, said in an interview. “Benefit leaders, finance leaders, and executives have not had the ability to make true data-driven decisions in terms of what kind of health care they procure for their populations, and they need to be able to do that.”
Employers using Collective Health still rely on insurance carriers to contract with networks of medical providers. But the company takes over some functions that traditional health plan administrators perform, like claims processing and customer service. Collective Health also analyzes claims data to recommend treatment options to members.
The San Francisco-based company has more than 500 employees and serves about 300,000 members across more than 55 companies, Diab said. Customers typically have at least 1,000 employees, and are self-insured – that is, they pay the medical costs for their health plans directly, and rely on insurance carriers only for administrative functions like contracting with doctors. Collective charges clients a per-employee-per-month fee for its service. Customers include Live Nation, Pinterest and Red Bull.
HCSC, a 16 million-member insurer that operates Blue Cross Blue Shield health plans in Illinois, Montana, New Mexico, Oklahoma, and Texas, was searching for technology that would improve the experience of both clients and their plan members.
“Health care is rather fragmented today, so we were looking to eliminate the fragmentation and really try to make giant steps in terms of technological improvement in the minds of our members and employers,” said Kevin Cassidy, HCSC's chief growth officer.
The deal with the insurer will accelerate Collective Health's reach with large employers, said Mohamad Makhzoumi, who leads the Global Healthcare Investing practice at venture firm New Enterprise Associates, Inc.
NEA first invested in Collective in 2014. A the time, Diab had no customers or even a beta product – simply “a really nice slide deck,” Makhzoumi said. Even with hundreds of thousands of members now, Makhzoumi said the challenge ahead for Collective Health is whether it can reach a scale needed to get the attention of the largest companies in market.
Digital health startups can have trouble gaining traction with larger companies in the $4.2 trillion U.S. health-care industry, he said. “It's kind of like, wake me up when you have a million lives,” he said, adding that he believes Collective Health will get there.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.